468 related articles for article (PubMed ID: 2549426)
21. Role of GTPases and GTPase regulatory proteins in oncogenesis.
Grunicke HH; Maly K
Crit Rev Oncog; 1993; 4(4):389-402. PubMed ID: 8353139
[TBL] [Abstract][Full Text] [Related]
22. Oncogenic mutations of alpha-Gi2 protein are not determinant for human adrenocortical tumourigenesis.
Gicquel C; Dib A; Bertagna X; Amselem S; Le Bouc Y
Eur J Endocrinol; 1995 Aug; 133(2):166-72. PubMed ID: 7655640
[TBL] [Abstract][Full Text] [Related]
23. Genomic sequence analysis of a key residue (Arg183) in human G alpha q in invasive non-functional pituitary adenomas.
Farrell WE; Talbot JA; Bicknell EJ; Simpson D; Clayton RN
Clin Endocrinol (Oxf); 1997 Aug; 47(2):241-4. PubMed ID: 9302401
[TBL] [Abstract][Full Text] [Related]
24. Gs alpha and Gi2 alpha mutations in clinically non-functioning pituitary tumours.
Williamson EA; Daniels M; Foster S; Kelly WF; Kendall-Taylor P; Harris PE
Clin Endocrinol (Oxf); 1994 Dec; 41(6):815-20. PubMed ID: 7889619
[TBL] [Abstract][Full Text] [Related]
25. The ras gene family.
Lowy DR; Willumsen BM
Cancer Surv; 1986; 5(2):275-89. PubMed ID: 3096566
[TBL] [Abstract][Full Text] [Related]
26. Similar characteristics of guanine nucleotide regulatory sites involved in adenylate cyclase activation, specific GTPase activity, and cholecystokinin binding in rat pancreatic plasma membranes.
Lambert M; Deschodt-Lanckman M; Furnelle J; Christophe J
J Cyclic Nucleotide Res; 1981; 7(6):385-97. PubMed ID: 6125533
[TBL] [Abstract][Full Text] [Related]
27. Relevant cAMP-specific phosphodiesterase isoforms in human pituitary: effect of Gs(alpha) mutations.
Persani L; Borgato S; Lania A; Filopanti M; Mantovani G; Conti M; Spada A
J Clin Endocrinol Metab; 2001 Aug; 86(8):3795-800. PubMed ID: 11502813
[TBL] [Abstract][Full Text] [Related]
28. Oncogenic role of heterotrimeric G proteins.
Vallar L
Cancer Surv; 1996; 27():325-38. PubMed ID: 8909808
[TBL] [Abstract][Full Text] [Related]
29. Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors.
Fragoso MC; Latronico AC; Carvalho FM; Zerbini MC; Marcondes JA; Araujo LM; Lando VS; Frazzatto ET; Mendonca BB; Villares SM
J Clin Endocrinol Metab; 1998 Jun; 83(6):2074-8. PubMed ID: 9626141
[TBL] [Abstract][Full Text] [Related]
30. GTPase and adenylate cyclase desensitize at different rates in NG108-15 cells.
Vachon L; Costa T; Herz A
Mol Pharmacol; 1987 Feb; 31(2):159-68. PubMed ID: 3027528
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein.
Landis CA; Harsh G; Lyons J; Davis RL; McCormick F; Bourne HR
J Clin Endocrinol Metab; 1990 Dec; 71(6):1416-20. PubMed ID: 2121775
[TBL] [Abstract][Full Text] [Related]
32. Growth hormone-prolactin-thyrotropin-secreting pituitary adenoma in atypical McCune-Albright syndrome with functionally normal Gs alpha protein.
Gessl A; Freissmuth M; Czech T; Matula C; Hainfellner JA; Buchfelder M; Vierhapper H
J Clin Endocrinol Metab; 1994 Oct; 79(4):1128-34. PubMed ID: 7962285
[TBL] [Abstract][Full Text] [Related]
33. Gs protein mutations and the pathogenesis and function of pituitary tumors.
Harris PE
Metabolism; 1996 Aug; 45(8 Suppl 1):120-2. PubMed ID: 8769404
[TBL] [Abstract][Full Text] [Related]
34. Expression of mutationally activated G alpha s stimulates growth and differentiation of thyroid FRTL5 cells.
Muca C; Vallar L
Oncogene; 1994 Dec; 9(12):3647-53. PubMed ID: 7526317
[TBL] [Abstract][Full Text] [Related]
35. Involvement of a high-affinity GTPase in the inhibitory coupling of striatal muscarinic receptors to adenylate cyclase.
Onali P; Olianas MC; Schwartz JP; Costa E
Mol Pharmacol; 1983 Nov; 24(3):380-6. PubMed ID: 6138702
[TBL] [Abstract][Full Text] [Related]
36. Mutations to forskolin resistance result in loss of adrenocorticotropin receptors and consequent reductions in levels of G protein alpha-subunits.
Qiu R; Tsao J; Kwan WK; Schimmer BP
Mol Endocrinol; 1996 Dec; 10(12):1708-18. PubMed ID: 8961279
[TBL] [Abstract][Full Text] [Related]
37. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.
Morita K; Takano K; Yasufuku-Takano J; Yamada S; Teramoto A; Takei M; Osamura RY; Sano T; Fujita T
Clin Endocrinol (Oxf); 2008 Mar; 68(3):435-41. PubMed ID: 18070145
[TBL] [Abstract][Full Text] [Related]
38. Separation and properties of a regulatory GTPase activity associated with the adenylate cyclase system in rat brain synaptic plasma membranes.
Enomoto K; Asakawa T
Biochem Int; 1983 Jan; 6(1):81-91. PubMed ID: 6148079
[TBL] [Abstract][Full Text] [Related]
39. A dominant negative G alpha s mutant is rescued by secondary mutation of the alpha chain amino terminus.
Osawa S; Johnson GL
J Biol Chem; 1991 Mar; 266(8):4673-6. PubMed ID: 1848223
[TBL] [Abstract][Full Text] [Related]
40. Predictive value of the analogy between hormone-sensitive adenylate cyclase and light-sensitive photoreceptor cyclic GMP phosphodiesterase: a specific role for a light-sensitive GTPase as a component in the activation sequence.
Shinozawa T; Sen I; Wheeler G; Bitensky M
J Supramol Struct; 1979; 10(2):185-90. PubMed ID: 222967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
